<?xml version="1.0"?>
<!DOCTYPE source_file SYSTEM "apf.v5.1.1.dtd">
<source_file URI="ZBN20001228.0400.0017.sgm" SOURCE="newswire" TYPE="text" AUTHOR="LDC" ENCODING="UTF-8">
<document DOCID="ZBN20001228.0400.0017">
<entity ID="ZBN20001228.0400.0017-E1" TYPE="ORG" SUBTYPE="Commercial" CLASS="SPC">
  <entity_mention ID="ZBN20001228.0400.0017-E1-2" TYPE="NOM" LDCTYPE="NOM">
    <extent>
      <charseq START="305" END="310">葛美两家公司</charseq>
    </extent>
    <head>
      <charseq START="309" END="310">公司</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E1-7" TYPE="NOM" LDCTYPE="NOM">
    <extent>
      <charseq START="356" END="357">公司</charseq>
    </extent>
    <head>
      <charseq START="356" END="357">公司</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E1-25" TYPE="PRO" LDCTYPE="PRO">
    <extent>
      <charseq START="507" END="508">双方</charseq>
    </extent>
    <head>
      <charseq START="507" END="508">双方</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E1-27" TYPE="PRO" LDCTYPE="PRO">
    <extent>
      <charseq START="537" END="538">双方</charseq>
    </extent>
    <head>
      <charseq START="537" END="538">双方</charseq>
    </head>
  </entity_mention>
</entity>
<entity ID="ZBN20001228.0400.0017-E2" TYPE="ORG" SUBTYPE="Government" CLASS="SPC">
  <entity_mention ID="ZBN20001228.0400.0017-E2-3" TYPE="NOM" LDCTYPE="NOM">
    <extent>
      <charseq START="337" END="342">美国管制当局</charseq>
    </extent>
    <head>
      <charseq START="341" END="342">当局</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E2-28" TYPE="NOM" LDCTYPE="NOM">
    <extent>
      <charseq START="552" END="555">管制当局</charseq>
    </extent>
    <head>
      <charseq START="554" END="555">当局</charseq>
    </head>
  </entity_mention>
</entity>
<entity ID="ZBN20001228.0400.0017-E3" TYPE="GPE" SUBTYPE="Nation" CLASS="SPC">
  <entity_mention ID="ZBN20001228.0400.0017-E3-4" TYPE="NAM" LDCTYPE="NAM" ROLE="GPE">
    <extent>
      <charseq START="337" END="338">美国</charseq>
    </extent>
    <head>
      <charseq START="337" END="338">美国</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E3-31" TYPE="NAM" LDCTYPE="NAM" ROLE="GPE">
    <extent>
      <charseq START="572" END="574">美
国</charseq>
    </extent>
    <head>
      <charseq START="572" END="574">美
国</charseq>
    </head>
  </entity_mention>
  <entity_attributes>
    <name NAME="美国">
      <charseq START="337" END="338">美国</charseq>
    </name>
    <name NAME="美 国">
      <charseq START="572" END="574">美
国</charseq>
    </name>
  </entity_attributes>
</entity>
<entity ID="ZBN20001228.0400.0017-E4" TYPE="ORG" SUBTYPE="Non-Governmental" CLASS="SPC">
  <entity_mention ID="ZBN20001228.0400.0017-E4-5" TYPE="NOM" LDCTYPE="NOM">
    <extent>
      <charseq START="350" END="354">欧盟委员会</charseq>
    </extent>
    <head>
      <charseq START="352" END="354">委员会</charseq>
    </head>
  </entity_mention>
</entity>
<entity ID="ZBN20001228.0400.0017-E5" TYPE="GPE" SUBTYPE="GPE-Cluster" CLASS="SPC">
  <entity_mention ID="ZBN20001228.0400.0017-E5-6" TYPE="NAM" LDCTYPE="NAM" ROLE="GPE">
    <extent>
      <charseq START="350" END="351">欧盟</charseq>
    </extent>
    <head>
      <charseq START="350" END="351">欧盟</charseq>
    </head>
  </entity_mention>
  <entity_attributes>
    <name NAME="欧盟">
      <charseq START="350" END="351">欧盟</charseq>
    </name>
  </entity_attributes>
</entity>
<entity ID="ZBN20001228.0400.0017-E6" TYPE="PER" SUBTYPE="Group" CLASS="SPC">
  <entity_mention ID="ZBN20001228.0400.0017-E6-8" TYPE="NOM" LDCTYPE="NOM">
    <extent>
      <charseq START="356" END="362">公司各自的股东</charseq>
    </extent>
    <head>
      <charseq START="361" END="362">股东</charseq>
    </head>
  </entity_mention>
</entity>
<entity ID="ZBN20001228.0400.0017-E7" TYPE="ORG" SUBTYPE="Commercial" CLASS="SPC">
  <entity_mention ID="ZBN20001228.0400.0017-E7-10" TYPE="NOM" LDCTYPE="NOM">
    <extent>
      <charseq START="402" END="410">任何一个药物制造商</charseq>
    </extent>
    <head>
      <charseq START="408" END="410">制造商</charseq>
    </head>
  </entity_mention>
</entity>
<entity ID="ZBN20001228.0400.0017-E8" TYPE="ORG" SUBTYPE="Commercial" CLASS="SPC">
  <entity_mention ID="ZBN20001228.0400.0017-E8-12" TYPE="NOM" LDCTYPE="NOM">
    <extent>
      <charseq START="420" END="425">全球药
物业</charseq>
    </extent>
    <head>
      <charseq START="422" END="425">药
物业</charseq>
    </head>
  </entity_mention>
</entity>
<entity ID="ZBN20001228.0400.0017-E9" TYPE="ORG" SUBTYPE="Commercial" CLASS="SPC">
  <entity_mention ID="ZBN20001228.0400.0017-E9-15" TYPE="NOM" LDCTYPE="NOM" LDCATR="TRUE">
    <extent>
      <charseq START="430" END="435">伟哥”制造商</charseq>
    </extent>
    <head>
      <charseq START="433" END="435">制造商</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E9-16" TYPE="NAM" LDCTYPE="NAM" LDCATR="FALSE">
    <extent>
      <charseq START="436" END="439">美国辉瑞</charseq>
    </extent>
    <head>
      <charseq START="436" END="439">美国辉瑞</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E9-17" TYPE="NAM" LDCTYPE="NAM" LDCATR="FALSE">
    <extent>
      <charseq START="441" END="446">Pfizer</charseq>
    </extent>
    <head>
      <charseq START="441" END="446">Pfizer</charseq>
    </head>
  </entity_mention>
  <entity_attributes>
    <name NAME="美国辉瑞">
      <charseq START="436" END="439">美国辉瑞</charseq>
    </name>
    <name NAME="Pfizer">
      <charseq START="441" END="446">Pfizer</charseq>
    </name>
  </entity_attributes>
</entity>
<entity ID="ZBN20001228.0400.0017-E11" TYPE="ORG" SUBTYPE="Commercial" CLASS="SPC">
  <entity_mention ID="ZBN20001228.0400.0017-E11-20" TYPE="NAM" LDCTYPE="NAM" LDCATR="FALSE">
    <extent>
      <charseq START="467" END="469">伏得风</charseq>
    </extent>
    <head>
      <charseq START="467" END="469">伏得风</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E11-21" TYPE="NOM" LDCTYPE="NOM" LDCATR="TRUE">
    <extent>
      <charseq START="463" END="466">手机公司</charseq>
    </extent>
    <head>
      <charseq START="465" END="466">公司</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E11-22" TYPE="NAM" LDCTYPE="NAM" LDCATR="FALSE">
    <extent>
      <charseq START="471" END="478">Vodafone</charseq>
    </extent>
    <head>
      <charseq START="471" END="478">Vodafone</charseq>
    </head>
  </entity_mention>
  <entity_attributes>
    <name NAME="伏得风">
      <charseq START="467" END="469">伏得风</charseq>
    </name>
    <name NAME="Vodafone">
      <charseq START="471" END="478">Vodafone</charseq>
    </name>
  </entity_attributes>
</entity>
<entity ID="ZBN20001228.0400.0017-E13" TYPE="ORG" SUBTYPE="Commercial" CLASS="SPC">
  <entity_mention ID="ZBN20001228.0400.0017-E13-23" TYPE="NAM" LDCTYPE="NAM">
    <extent>
      <charseq START="481" END="487">英国
石油公司</charseq>
    </extent>
    <head>
      <charseq START="481" END="487">英国
石油公司</charseq>
    </head>
  </entity_mention>
  <entity_attributes>
    <name NAME="英国 石油公司">
      <charseq START="481" END="487">英国
石油公司</charseq>
    </name>
  </entity_attributes>
</entity>
<entity ID="ZBN20001228.0400.0017-E14" TYPE="ORG" SUBTYPE="Commercial" CLASS="GEN">
  <entity_mention ID="ZBN20001228.0400.0017-E14-24" TYPE="NOM" LDCTYPE="NOM">
    <extent>
      <charseq START="452" END="454">企
业</charseq>
    </extent>
    <head>
      <charseq START="452" END="454">企
业</charseq>
    </head>
  </entity_mention>
</entity>
<entity ID="ZBN20001228.0400.0017-E15" TYPE="ORG" SUBTYPE="Government" CLASS="SPC">
  <entity_mention ID="ZBN20001228.0400.0017-E15-29" TYPE="NOM" LDCTYPE="NOM">
    <extent>
      <charseq START="313" END="314">当局</charseq>
    </extent>
    <head>
      <charseq START="313" END="314">当局</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E15-30" TYPE="NOM" LDCTYPE="NOM">
    <extent>
      <charseq START="572" END="576">美
国当局</charseq>
    </extent>
    <head>
      <charseq START="575" END="576">当局</charseq>
    </head>
  </entity_mention>
</entity>
<entity ID="ZBN20001228.0400.0017-E16" TYPE="ORG" SUBTYPE="Commercial" CLASS="SPC">
  <entity_mention ID="ZBN20001228.0400.0017-E16-34" TYPE="NOM" LDCTYPE="NOM" LDCATR="TRUE">
    <extent>
      <charseq START="640" END="643">瑞士公司</charseq>
    </extent>
    <head>
      <charseq START="642" END="643">公司</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E16-35" TYPE="NAM" LDCTYPE="NAM" LDCATR="FALSE">
    <extent>
      <charseq START="644" END="647">诺瓦蒂斯</charseq>
    </extent>
    <head>
      <charseq START="644" END="647">诺瓦蒂斯</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E16-36" TYPE="NAM" LDCTYPE="NAM" LDCATR="FALSE">
    <extent>
      <charseq START="649" END="657">Norvartis</charseq>
    </extent>
    <head>
      <charseq START="649" END="657">Norvartis</charseq>
    </head>
  </entity_mention>
  <entity_attributes>
    <name NAME="诺瓦蒂斯">
      <charseq START="644" END="647">诺瓦蒂斯</charseq>
    </name>
    <name NAME="Norvartis">
      <charseq START="649" END="657">Norvartis</charseq>
    </name>
  </entity_attributes>
</entity>
<entity ID="ZBN20001228.0400.0017-E18" TYPE="GPE" SUBTYPE="Nation" CLASS="SPC">
  <entity_mention ID="ZBN20001228.0400.0017-E18-37" TYPE="NAM" LDCTYPE="NAM" ROLE="GPE">
    <extent>
      <charseq START="640" END="641">瑞士</charseq>
    </extent>
    <head>
      <charseq START="640" END="641">瑞士</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E18-39" TYPE="NAM" LDCTYPE="NAM" ROLE="GPE">
    <extent>
      <charseq START="687" END="688">瑞士</charseq>
    </extent>
    <head>
      <charseq START="687" END="688">瑞士</charseq>
    </head>
  </entity_mention>
  <entity_attributes>
    <name NAME="瑞士">
      <charseq START="640" END="641">瑞士</charseq>
    </name>
    <name NAME="瑞士">
      <charseq START="687" END="688">瑞士</charseq>
    </name>
  </entity_attributes>
</entity>
<entity ID="ZBN20001228.0400.0017-E19" TYPE="ORG" SUBTYPE="Commercial" CLASS="SPC">
  <entity_mention ID="ZBN20001228.0400.0017-E19-38" TYPE="NAM" LDCTYPE="NAM">
    <extent>
      <charseq START="687" END="693">瑞士的罗赫公司</charseq>
    </extent>
    <head>
      <charseq START="690" END="693">罗赫公司</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E19-40" TYPE="NAM" LDCTYPE="NAM">
    <extent>
      <charseq START="695" END="699">Roche</charseq>
    </extent>
    <head>
      <charseq START="695" END="699">Roche</charseq>
    </head>
  </entity_mention>
  <entity_attributes>
    <name NAME="罗赫公司">
      <charseq START="690" END="693">罗赫公司</charseq>
    </name>
    <name NAME="Roche">
      <charseq START="695" END="699">Roche</charseq>
    </name>
  </entity_attributes>
</entity>
<entity ID="ZBN20001228.0400.0017-E20" TYPE="GPE" SUBTYPE="Population-Center" CLASS="SPC">
  <entity_mention ID="ZBN20001228.0400.0017-E20-1" TYPE="NAM" LDCTYPE="NAM" ROLE="LOC">
    <extent>
      <charseq START="74" END="75">伦敦</charseq>
    </extent>
    <head>
      <charseq START="74" END="75">伦敦</charseq>
    </head>
  </entity_mention>
  <entity_attributes>
    <name NAME="伦敦">
      <charseq START="74" END="75">伦敦</charseq>
    </name>
  </entity_attributes>
</entity>
<entity ID="ZBN20001228.0400.0017-E21" TYPE="ORG" SUBTYPE="Media" CLASS="SPC">
  <entity_mention ID="ZBN20001228.0400.0017-E21-41" TYPE="NAM" LDCTYPE="NAM">
    <extent>
      <charseq START="76" END="77">法新</charseq>
    </extent>
    <head>
      <charseq START="76" END="77">法新</charseq>
    </head>
  </entity_mention>
  <entity_attributes>
    <name NAME="法新">
      <charseq START="76" END="77">法新</charseq>
    </name>
  </entity_attributes>
</entity>
<entity ID="ZBN20001228.0400.0017-E22" TYPE="ORG" SUBTYPE="Commercial" CLASS="SPC">
  <entity_mention ID="ZBN20001228.0400.0017-E22-43" TYPE="NOM" LDCTYPE="NOM" LDCATR="TRUE">
    <extent>
      <charseq START="80" END="86">英国药物业巨擘</charseq>
    </extent>
    <head>
      <charseq START="85" END="86">巨擘</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E22-44" TYPE="NAM" LDCTYPE="NAM" LDCATR="FALSE">
    <extent>
      <charseq START="87" END="93">葛兰素威康公司</charseq>
    </extent>
    <head>
      <charseq START="87" END="93">葛兰素威康公司</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E22-45" TYPE="NAM" LDCTYPE="NAM" LDCATR="FALSE">
    <extent>
      <charseq START="95" END="107">GlaxoWellcome</charseq>
    </extent>
    <head>
      <charseq START="95" END="107">GlaxoWellcome</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E22-57" TYPE="NAM" LDCTYPE="NAM" LDCATR="FALSE">
    <extent>
      <charseq START="305" END="305">葛</charseq>
    </extent>
    <head>
      <charseq START="305" END="305">葛</charseq>
    </head>
  </entity_mention>
  <entity_attributes>
    <name NAME="葛兰素威康公司">
      <charseq START="87" END="93">葛兰素威康公司</charseq>
    </name>
    <name NAME="GlaxoWellcome">
      <charseq START="95" END="107">GlaxoWellcome</charseq>
    </name>
    <name NAME="葛">
      <charseq START="305" END="305">葛</charseq>
    </name>
  </entity_attributes>
</entity>
<entity ID="ZBN20001228.0400.0017-E24" TYPE="GPE" SUBTYPE="Nation" CLASS="SPC">
  <entity_mention ID="ZBN20001228.0400.0017-E24-18" TYPE="NAM" LDCTYPE="NAM" ROLE="GPE">
    <extent>
      <charseq START="450" END="451">英国</charseq>
    </extent>
    <head>
      <charseq START="450" END="451">英国</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E24-46" TYPE="NAM" LDCTYPE="NAM" ROLE="GPE">
    <extent>
      <charseq START="80" END="81">英国</charseq>
    </extent>
    <head>
      <charseq START="80" END="81">英国</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E24-53" TYPE="NAM" LDCTYPE="NAM" ROLE="GPE">
    <extent>
      <charseq START="174" END="175">英国</charseq>
    </extent>
    <head>
      <charseq START="174" END="175">英国</charseq>
    </head>
  </entity_mention>
  <entity_attributes>
    <name NAME="英国">
      <charseq START="450" END="451">英国</charseq>
    </name>
    <name NAME="英国">
      <charseq START="80" END="81">英国</charseq>
    </name>
    <name NAME="英国">
      <charseq START="174" END="175">英国</charseq>
    </name>
  </entity_attributes>
</entity>
<entity ID="ZBN20001228.0400.0017-E25" TYPE="ORG" SUBTYPE="Commercial" CLASS="SPC">
  <entity_mention ID="ZBN20001228.0400.0017-E25-47" TYPE="NOM" LDCTYPE="NOM">
    <extent>
      <charseq START="80" END="84">英国药物业</charseq>
    </extent>
    <head>
      <charseq START="82" END="84">药物业</charseq>
    </head>
  </entity_mention>
</entity>
<entity ID="ZBN20001228.0400.0017-E26" TYPE="ORG" SUBTYPE="Commercial" CLASS="SPC">
  <entity_mention ID="ZBN20001228.0400.0017-E26-32" TYPE="NAM" LDCTYPE="NAM">
    <extent>
      <charseq START="580" END="581">美占</charseq>
    </extent>
    <head>
      <charseq START="580" END="581">美占</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E26-48" TYPE="NAM" LDCTYPE="NAM">
    <extent>
      <charseq START="111" END="114">美占公司</charseq>
    </extent>
    <head>
      <charseq START="111" END="114">美占公司</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E26-49" TYPE="NAM" LDCTYPE="NAM">
    <extent>
      <charseq START="116" END="133">SmithKline Beecham</charseq>
    </extent>
    <head>
      <charseq START="116" END="133">SmithKline Beecham</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E26-58" TYPE="NAM" LDCTYPE="NAM">
    <extent>
      <charseq START="306" END="306">美</charseq>
    </extent>
    <head>
      <charseq START="306" END="306">美</charseq>
    </head>
  </entity_mention>
  <entity_attributes>
    <name NAME="美占">
      <charseq START="580" END="581">美占</charseq>
    </name>
    <name NAME="美占公司">
      <charseq START="111" END="114">美占公司</charseq>
    </name>
    <name NAME="SmithKline Beecham">
      <charseq START="116" END="133">SmithKline Beecham</charseq>
    </name>
    <name NAME="美">
      <charseq START="306" END="306">美</charseq>
    </name>
  </entity_attributes>
</entity>
<entity ID="ZBN20001228.0400.0017-E27" TYPE="ORG" SUBTYPE="Commercial" CLASS="SPC">
  <entity_mention ID="ZBN20001228.0400.0017-E27-9" TYPE="NOM" LDCTYPE="NOM" LDCATR="FALSE">
    <extent>
      <charseq START="378" END="380">新公司</charseq>
    </extent>
    <head>
      <charseq START="379" END="380">公司</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E27-11" TYPE="PRO" LDCTYPE="PRO" LDCATR="FALSE">
    <extent>
      <charseq START="418" END="418">它</charseq>
    </extent>
    <head>
      <charseq START="418" END="418">它</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E27-26" TYPE="NOM" LDCTYPE="NOM" LDCATR="FALSE">
    <extent>
      <charseq START="516" END="518">新公司</charseq>
    </extent>
    <head>
      <charseq START="517" END="518">公司</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E27-51" TYPE="NOM" LDCTYPE="NOM" LDCATR="FALSE">
    <extent>
      <charseq START="174" END="180">英国第三大企业</charseq>
    </extent>
    <head>
      <charseq START="179" END="180">企业</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E27-52" TYPE="NOM" LDCTYPE="NOM" LDCATR="TRUE">
    <extent>
      <charseq START="154" END="170">全球药物市场占有率最高的药物集
团</charseq>
    </extent>
    <head>
      <charseq START="168" END="170">集
团</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E27-54" TYPE="NOM" LDCTYPE="NOM" LDCATR="FALSE">
    <extent>
      <charseq START="183" END="185">新公司</charseq>
    </extent>
    <head>
      <charseq START="184" END="185">公司</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E27-55" TYPE="NAM" LDCTYPE="NAM" LDCATR="FALSE">
    <extent>
      <charseq START="188" END="215">葛兰素史密斯克兰（GlaxoSmithKline）
集团</charseq>
    </extent>
    <head>
      <charseq START="188" END="215">葛兰素史密斯克兰（GlaxoSmithKline）
集团</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E27-56" TYPE="NOM" LDCTYPE="NOM" LDCATR="FALSE">
    <extent>
      <charseq START="241" END="244">新公
司</charseq>
    </extent>
    <head>
      <charseq START="242" END="244">公
司</charseq>
    </head>
  </entity_mention>
  <entity_attributes>
    <name NAME="葛兰素史密斯克兰（GlaxoSmithKline） 集团">
      <charseq START="188" END="215">葛兰素史密斯克兰（GlaxoSmithKline）
集团</charseq>
    </name>
  </entity_attributes>
</entity>
<entity ID="ZBN20001228.0400.0017-E28" TYPE="LOC" SUBTYPE="Celestial" CLASS="SPC">
  <entity_mention ID="ZBN20001228.0400.0017-E28-13" TYPE="NOM" LDCTYPE="NOM">
    <extent>
      <charseq START="420" END="421">全球</charseq>
    </extent>
    <head>
      <charseq START="420" END="421">全球</charseq>
    </head>
  </entity_mention>
  <entity_mention ID="ZBN20001228.0400.0017-E28-50" TYPE="NOM" LDCTYPE="NOM">
    <extent>
      <charseq START="154" END="155">全球</charseq>
    </extent>
    <head>
      <charseq START="154" END="155">全球</charseq>
    </head>
  </entity_mention>
</entity>
<value ID="ZBN20001228.0400.0017-V1" TYPE="Numeric" SUBTYPE="Money">
  <value_mention ID="ZBN20001228.0400.0017-V1-1">
    <extent>
      <charseq START="222" END="228">1140亿英镑</charseq>
    </extent>
  </value_mention>
</value>
<value ID="ZBN20001228.0400.0017-V2" TYPE="Numeric" SUBTYPE="Money">
  <value_mention ID="ZBN20001228.0400.0017-V2-1">
    <extent>
      <charseq START="231" END="237">2918亿新元</charseq>
    </extent>
  </value_mention>
</value>
<value ID="ZBN20001228.0400.0017-V3" TYPE="Numeric" SUBTYPE="Money">
  <value_mention ID="ZBN20001228.0400.0017-V3-1">
    <extent>
      <charseq START="258" END="264">18.31英镑</charseq>
    </extent>
  </value_mention>
</value>
<value ID="ZBN20001228.0400.0017-V4" TYPE="Numeric" SUBTYPE="Money">
  <value_mention ID="ZBN20001228.0400.0017-V4-1">
    <extent>
      <charseq START="277" END="283">18.43英镑</charseq>
    </extent>
  </value_mention>
</value>
<value ID="ZBN20001228.0400.0017-V5" TYPE="Numeric" SUBTYPE="Percent">
  <value_mention ID="ZBN20001228.0400.0017-V5-1">
    <extent>
      <charseq START="394" END="397">7%，年</charseq>
    </extent>
  </value_mention>
</value>
<value ID="ZBN20001228.0400.0017-V6" TYPE="Numeric" SUBTYPE="Money">
  <value_mention ID="ZBN20001228.0400.0017-V6-1">
    <extent>
      <charseq START="588" END="597">16亿3000万美元</charseq>
    </extent>
  </value_mention>
</value>
<value ID="ZBN20001228.0400.0017-V7" TYPE="Numeric" SUBTYPE="Money">
  <value_mention ID="ZBN20001228.0400.0017-V7-1">
    <extent>
      <charseq START="600" END="605">28亿
新元</charseq>
    </extent>
  </value_mention>
</value>
<value ID="ZBN20001228.0400.0017-V8" TYPE="Numeric" SUBTYPE="Money">
  <value_mention ID="ZBN20001228.0400.0017-V8-1">
    <extent>
      <charseq START="664" END="674">12亿
3000万美元</charseq>
    </extent>
  </value_mention>
</value>
<timex2 ID="ZBN20001228.0400.0017-T1">
  <timex2_mention ID="ZBN20001228.0400.0017-T1-1">
    <extent>
      <charseq START="39" END="48">2000-12-28</charseq>
    </extent>
  </timex2_mention>
</timex2>
<timex2 ID="ZBN20001228.0400.0017-T2">
  <timex2_mention ID="ZBN20001228.0400.0017-T2-1">
    <extent>
      <charseq START="141" END="142">昨天</charseq>
    </extent>
  </timex2_mention>
</timex2>
<timex2 ID="ZBN20001228.0400.0017-T3">
  <timex2_mention ID="ZBN20001228.0400.0017-T3-1">
    <extent>
      <charseq START="249" END="250">昨天</charseq>
    </extent>
  </timex2_mention>
</timex2>
<timex2 ID="ZBN20001228.0400.0017-T4">
  <timex2_mention ID="ZBN20001228.0400.0017-T4-1">
    <extent>
      <charseq START="298" END="300">上星期</charseq>
    </extent>
  </timex2_mention>
</timex2>
<timex2 ID="ZBN20001228.0400.0017-T5">
  <timex2_mention ID="ZBN20001228.0400.0017-T5-1">
    <extent>
      <charseq START="364" END="366">较早时</charseq>
    </extent>
  </timex2_mention>
</timex2>
<timex2 ID="ZBN20001228.0400.0017-T6">
  <timex2_mention ID="ZBN20001228.0400.0017-T6-1">
    <extent>
      <charseq START="499" END="503">1997年</charseq>
    </extent>
  </timex2_mention>
</timex2>
<timex2 ID="ZBN20001228.0400.0017-T7">
  <timex2_mention ID="ZBN20001228.0400.0017-T7-1">
    <extent>
      <charseq START="532" END="535">今年1月</charseq>
    </extent>
  </timex2_mention>
</timex2>
<timex2 ID="ZBN20001228.0400.0017-T8">
  <timex2_mention ID="ZBN20001228.0400.0017-T8-1">
    <extent>
      <charseq START="582" END="583">8月</charseq>
    </extent>
  </timex2_mention>
</timex2>
<relation ID="ZBN20001228.0400.0017-R1" TYPE="GEN-AFF" SUBTYPE="Org-Location" TENSE="Present" MODALITY="Asserted">
  <relation_argument REFID="ZBN20001228.0400.0017-E21" ROLE="Arg-1"/>
  <relation_argument REFID="ZBN20001228.0400.0017-E20" ROLE="Arg-2"/>
  <relation_mention ID="ZBN20001228.0400.0017-R1-1" LEXICALCONDITION="Formulaic">
    <extent>
      <charseq START="74" END="77">伦敦法新</charseq>
    </extent>
    <relation_mention_argument REFID="ZBN20001228.0400.0017-E21-41" ROLE="Arg-1">
      <extent>
        <charseq START="76" END="77">法新</charseq>
      </extent>
    </relation_mention_argument>
    <relation_mention_argument REFID="ZBN20001228.0400.0017-E20-1" ROLE="Arg-2">
      <extent>
        <charseq START="74" END="75">伦敦</charseq>
      </extent>
    </relation_mention_argument>
  </relation_mention>
</relation>
<relation ID="ZBN20001228.0400.0017-R2" TYPE="GEN-AFF" SUBTYPE="Org-Location" TENSE="Unspecified" MODALITY="Asserted">
  <relation_argument REFID="ZBN20001228.0400.0017-E25" ROLE="Arg-1"/>
  <relation_argument REFID="ZBN20001228.0400.0017-E24" ROLE="Arg-2"/>
  <relation_mention ID="ZBN20001228.0400.0017-R2-1" LEXICALCONDITION="PreMod">
    <extent>
      <charseq START="80" END="84">英国药物业</charseq>
    </extent>
    <relation_mention_argument REFID="ZBN20001228.0400.0017-E25-47" ROLE="Arg-1">
      <extent>
        <charseq START="80" END="84">英国药物业</charseq>
      </extent>
    </relation_mention_argument>
    <relation_mention_argument REFID="ZBN20001228.0400.0017-E24-46" ROLE="Arg-2">
      <extent>
        <charseq START="80" END="81">英国</charseq>
      </extent>
    </relation_mention_argument>
  </relation_mention>
</relation>
<relation ID="ZBN20001228.0400.0017-R3" TYPE="GEN-AFF" SUBTYPE="Org-Location" TENSE="Unspecified" MODALITY="Asserted">
  <relation_argument REFID="ZBN20001228.0400.0017-E22" ROLE="Arg-1"/>
  <relation_argument REFID="ZBN20001228.0400.0017-E24" ROLE="Arg-2"/>
  <relation_mention ID="ZBN20001228.0400.0017-R3-1" LEXICALCONDITION="PreMod">
    <extent>
      <charseq START="80" END="86">英国药物业巨擘</charseq>
    </extent>
    <relation_mention_argument REFID="ZBN20001228.0400.0017-E22-43" ROLE="Arg-1">
      <extent>
        <charseq START="80" END="86">英国药物业巨擘</charseq>
      </extent>
    </relation_mention_argument>
    <relation_mention_argument REFID="ZBN20001228.0400.0017-E24-46" ROLE="Arg-2">
      <extent>
        <charseq START="80" END="81">英国</charseq>
      </extent>
    </relation_mention_argument>
  </relation_mention>
</relation>
<relation ID="ZBN20001228.0400.0017-R4" TYPE="GEN-AFF" SUBTYPE="Org-Location" TENSE="Unspecified" MODALITY="Asserted">
  <relation_argument REFID="ZBN20001228.0400.0017-E27" ROLE="Arg-1"/>
  <relation_argument REFID="ZBN20001228.0400.0017-E28" ROLE="Arg-2"/>
  <relation_mention ID="ZBN20001228.0400.0017-R4-1" LEXICALCONDITION="PreMod">
    <extent>
      <charseq START="154" END="170">全球药物市场占有率最高的药物集
团</charseq>
    </extent>
    <relation_mention_argument REFID="ZBN20001228.0400.0017-E27-52" ROLE="Arg-1">
      <extent>
        <charseq START="154" END="170">全球药物市场占有率最高的药物集
团</charseq>
      </extent>
    </relation_mention_argument>
    <relation_mention_argument REFID="ZBN20001228.0400.0017-E28-50" ROLE="Arg-2">
      <extent>
        <charseq START="154" END="155">全球</charseq>
      </extent>
    </relation_mention_argument>
  </relation_mention>
</relation>
<relation ID="ZBN20001228.0400.0017-R5" TYPE="GEN-AFF" SUBTYPE="Org-Location" TENSE="Unspecified" MODALITY="Asserted">
  <relation_argument REFID="ZBN20001228.0400.0017-E27" ROLE="Arg-1"/>
  <relation_argument REFID="ZBN20001228.0400.0017-E24" ROLE="Arg-2"/>
  <relation_mention ID="ZBN20001228.0400.0017-R5-1" LEXICALCONDITION="PreMod">
    <extent>
      <charseq START="174" END="180">英国第三大企业</charseq>
    </extent>
    <relation_mention_argument REFID="ZBN20001228.0400.0017-E27-51" ROLE="Arg-1">
      <extent>
        <charseq START="174" END="180">英国第三大企业</charseq>
      </extent>
    </relation_mention_argument>
    <relation_mention_argument REFID="ZBN20001228.0400.0017-E24-53" ROLE="Arg-2">
      <extent>
        <charseq START="174" END="175">英国</charseq>
      </extent>
    </relation_mention_argument>
  </relation_mention>
</relation>
<relation ID="ZBN20001228.0400.0017-R6" TYPE="PART-WHOLE" SUBTYPE="Subsidiary" TENSE="Unspecified" MODALITY="Asserted">
  <relation_argument REFID="ZBN20001228.0400.0017-E2" ROLE="Arg-1"/>
  <relation_argument REFID="ZBN20001228.0400.0017-E3" ROLE="Arg-2"/>
  <relation_mention ID="ZBN20001228.0400.0017-R6-1" LEXICALCONDITION="PreMod">
    <extent>
      <charseq START="337" END="342">美国管制当局</charseq>
    </extent>
    <relation_mention_argument REFID="ZBN20001228.0400.0017-E2-3" ROLE="Arg-1">
      <extent>
        <charseq START="337" END="342">美国管制当局</charseq>
      </extent>
    </relation_mention_argument>
    <relation_mention_argument REFID="ZBN20001228.0400.0017-E3-4" ROLE="Arg-2">
      <extent>
        <charseq START="337" END="338">美国</charseq>
      </extent>
    </relation_mention_argument>
  </relation_mention>
</relation>
<relation ID="ZBN20001228.0400.0017-R7" TYPE="PART-WHOLE" SUBTYPE="Subsidiary" TENSE="Unspecified" MODALITY="Asserted">
  <relation_argument REFID="ZBN20001228.0400.0017-E4" ROLE="Arg-1"/>
  <relation_argument REFID="ZBN20001228.0400.0017-E5" ROLE="Arg-2"/>
  <relation_mention ID="ZBN20001228.0400.0017-R7-1" LEXICALCONDITION="PreMod">
    <extent>
      <charseq START="350" END="354">欧盟委员会</charseq>
    </extent>
    <relation_mention_argument REFID="ZBN20001228.0400.0017-E4-5" ROLE="Arg-1">
      <extent>
        <charseq START="350" END="354">欧盟委员会</charseq>
      </extent>
    </relation_mention_argument>
    <relation_mention_argument REFID="ZBN20001228.0400.0017-E5-6" ROLE="Arg-2">
      <extent>
        <charseq START="350" END="351">欧盟</charseq>
      </extent>
    </relation_mention_argument>
  </relation_mention>
</relation>
<relation ID="ZBN20001228.0400.0017-R8" TYPE="ORG-AFF" SUBTYPE="Investor-Shareholder" TENSE="Unspecified" MODALITY="Asserted">
  <relation_argument REFID="ZBN20001228.0400.0017-E6" ROLE="Arg-1"/>
  <relation_argument REFID="ZBN20001228.0400.0017-E1" ROLE="Arg-2"/>
  <relation_mention ID="ZBN20001228.0400.0017-R8-1" LEXICALCONDITION="PreMod">
    <extent>
      <charseq START="356" END="362">公司各自的股东</charseq>
    </extent>
    <relation_mention_argument REFID="ZBN20001228.0400.0017-E6-8" ROLE="Arg-1">
      <extent>
        <charseq START="356" END="362">公司各自的股东</charseq>
      </extent>
    </relation_mention_argument>
    <relation_mention_argument REFID="ZBN20001228.0400.0017-E1-7" ROLE="Arg-2">
      <extent>
        <charseq START="356" END="357">公司</charseq>
      </extent>
    </relation_mention_argument>
  </relation_mention>
</relation>
<relation ID="ZBN20001228.0400.0017-R9" TYPE="GEN-AFF" SUBTYPE="Org-Location" TENSE="Unspecified" MODALITY="Asserted">
  <relation_argument REFID="ZBN20001228.0400.0017-E8" ROLE="Arg-1"/>
  <relation_argument REFID="ZBN20001228.0400.0017-E28" ROLE="Arg-2"/>
  <relation_mention ID="ZBN20001228.0400.0017-R9-1" LEXICALCONDITION="PreMod">
    <extent>
      <charseq START="420" END="425">全球药
物业</charseq>
    </extent>
    <relation_mention_argument REFID="ZBN20001228.0400.0017-E8-12" ROLE="Arg-1">
      <extent>
        <charseq START="420" END="425">全球药
物业</charseq>
      </extent>
    </relation_mention_argument>
    <relation_mention_argument REFID="ZBN20001228.0400.0017-E28-13" ROLE="Arg-2">
      <extent>
        <charseq START="420" END="421">全球</charseq>
      </extent>
    </relation_mention_argument>
  </relation_mention>
</relation>
<relation ID="ZBN20001228.0400.0017-R10" TYPE="PART-WHOLE" SUBTYPE="Subsidiary" TENSE="Unspecified" MODALITY="Asserted">
  <relation_argument REFID="ZBN20001228.0400.0017-E15" ROLE="Arg-1"/>
  <relation_argument REFID="ZBN20001228.0400.0017-E3" ROLE="Arg-2"/>
  <relation_mention ID="ZBN20001228.0400.0017-R10-1" LEXICALCONDITION="PreMod">
    <extent>
      <charseq START="572" END="576">美
国当局</charseq>
    </extent>
    <relation_mention_argument REFID="ZBN20001228.0400.0017-E15-30" ROLE="Arg-1">
      <extent>
        <charseq START="572" END="576">美
国当局</charseq>
      </extent>
    </relation_mention_argument>
    <relation_mention_argument REFID="ZBN20001228.0400.0017-E3-31" ROLE="Arg-2">
      <extent>
        <charseq START="572" END="574">美
国</charseq>
      </extent>
    </relation_mention_argument>
  </relation_mention>
</relation>
<relation ID="ZBN20001228.0400.0017-R11" TYPE="GEN-AFF" SUBTYPE="Org-Location" TENSE="Unspecified" MODALITY="Asserted">
  <relation_argument REFID="ZBN20001228.0400.0017-E16" ROLE="Arg-1"/>
  <relation_argument REFID="ZBN20001228.0400.0017-E18" ROLE="Arg-2"/>
  <relation_mention ID="ZBN20001228.0400.0017-R11-1" LEXICALCONDITION="PreMod">
    <extent>
      <charseq START="640" END="643">瑞士公司</charseq>
    </extent>
    <relation_mention_argument REFID="ZBN20001228.0400.0017-E16-34" ROLE="Arg-1">
      <extent>
        <charseq START="640" END="643">瑞士公司</charseq>
      </extent>
    </relation_mention_argument>
    <relation_mention_argument REFID="ZBN20001228.0400.0017-E18-37" ROLE="Arg-2">
      <extent>
        <charseq START="640" END="641">瑞士</charseq>
      </extent>
    </relation_mention_argument>
  </relation_mention>
</relation>
<relation ID="ZBN20001228.0400.0017-R12" TYPE="GEN-AFF" SUBTYPE="Org-Location" TENSE="Unspecified" MODALITY="Asserted">
  <relation_argument REFID="ZBN20001228.0400.0017-E19" ROLE="Arg-1"/>
  <relation_argument REFID="ZBN20001228.0400.0017-E18" ROLE="Arg-2"/>
  <relation_mention ID="ZBN20001228.0400.0017-R12-1" LEXICALCONDITION="PreMod">
    <extent>
      <charseq START="687" END="693">瑞士的罗赫公司</charseq>
    </extent>
    <relation_mention_argument REFID="ZBN20001228.0400.0017-E19-38" ROLE="Arg-1">
      <extent>
        <charseq START="687" END="693">瑞士的罗赫公司</charseq>
      </extent>
    </relation_mention_argument>
    <relation_mention_argument REFID="ZBN20001228.0400.0017-E18-39" ROLE="Arg-2">
      <extent>
        <charseq START="687" END="688">瑞士</charseq>
      </extent>
    </relation_mention_argument>
  </relation_mention>
</relation>
<event ID="ZBN20001228.0400.0017-EV1" TYPE="Business" SUBTYPE="Merge-Org" MODALITY="Asserted" POLARITY="Positive" GENERICITY="Specific" TENSE="Past">
  <event_argument REFID="ZBN20001228.0400.0017-E22" ROLE="Org"/>
  <event_argument REFID="ZBN20001228.0400.0017-E26" ROLE="Org"/>
  <event_argument REFID="ZBN20001228.0400.0017-T2" ROLE="Time-Within"/>
  <event_argument REFID="ZBN20001228.0400.0017-E1" ROLE="Org"/>
  <event_mention ID="ZBN20001228.0400.0017-EV1-1">
    <extent>
      <charseq START="87" END="148">葛兰素威康公司（GlaxoWellcome）
和美占公司（SmithKline Beecham）几经波折
，昨天终于达成合并</charseq>
    </extent>
    <ldc_scope>
      <charseq START="80" END="180">英国药物业巨擘葛兰素威康公司（GlaxoWellcome）
和美占公司（SmithKline Beecham）几经波折
，昨天终于达成合并协议，成为全球药物市场占有率最高的药物集
团，也是英国第三大企业</charseq>
    </ldc_scope>
    <anchor>
      <charseq START="147" END="148">合并</charseq>
    </anchor>
    <event_mention_argument REFID="ZBN20001228.0400.0017-E22-44" ROLE="Org">
      <extent>
        <charseq START="87" END="93">葛兰素威康公司</charseq>
      </extent>
    </event_mention_argument>
    <event_mention_argument REFID="ZBN20001228.0400.0017-E26-48" ROLE="Org">
      <extent>
        <charseq START="111" END="114">美占公司</charseq>
      </extent>
    </event_mention_argument>
    <event_mention_argument REFID="ZBN20001228.0400.0017-T2-1" ROLE="Time-Within">
      <extent>
        <charseq START="141" END="142">昨天</charseq>
      </extent>
    </event_mention_argument>
  </event_mention>
  <event_mention ID="ZBN20001228.0400.0017-EV1-2">
    <extent>
      <charseq START="286" END="306">合并计划的最后一道障碍于上星期清除
，葛美</charseq>
    </extent>
    <ldc_scope>
      <charseq START="286" END="348">合并计划的最后一道障碍于上星期清除
，葛美两家公司为免当局以反垄断为由阻挠合并，出售了旗下一些
产品，美国管制当局随后给予首肯</charseq>
    </ldc_scope>
    <anchor>
      <charseq START="286" END="287">合并</charseq>
    </anchor>
    <event_mention_argument REFID="ZBN20001228.0400.0017-E22-57" ROLE="Org">
      <extent>
        <charseq START="305" END="305">葛</charseq>
      </extent>
    </event_mention_argument>
    <event_mention_argument REFID="ZBN20001228.0400.0017-E26-58" ROLE="Org">
      <extent>
        <charseq START="306" END="306">美</charseq>
      </extent>
    </event_mention_argument>
  </event_mention>
  <event_mention ID="ZBN20001228.0400.0017-EV1-3">
    <extent>
      <charseq START="370" END="371">合并</charseq>
    </extent>
    <ldc_scope>
      <charseq START="350" END="375">欧盟委员会和公司各自的股东
较早时也已对合并计划点头</charseq>
    </ldc_scope>
    <anchor>
      <charseq START="370" END="371">合并</charseq>
    </anchor>
  </event_mention>
  <event_mention ID="ZBN20001228.0400.0017-EV1-4">
    <extent>
      <charseq START="492" END="508">合并计划最初在1997年提出，双方</charseq>
    </extent>
    <ldc_scope>
      <charseq START="492" END="529">合并计划最初在1997年提出，双方为了谁该
主导新公司的问题而交恶，合并告吹</charseq>
    </ldc_scope>
    <anchor>
      <charseq START="492" END="493">合并</charseq>
    </anchor>
    <event_mention_argument REFID="ZBN20001228.0400.0017-E1-25" ROLE="Org">
      <extent>
        <charseq START="507" END="508">双方</charseq>
      </extent>
    </event_mention_argument>
  </event_mention>
  <event_mention ID="ZBN20001228.0400.0017-EV1-5">
    <extent>
      <charseq START="537" END="545">双方提出新的
合并</charseq>
    </extent>
    <ldc_scope>
      <charseq START="532" END="566">今年1月，双方提出新的
合并计划，但因为管制当局存有疑虑而两度延期落实</charseq>
    </ldc_scope>
    <anchor>
      <charseq START="544" END="545">合并</charseq>
    </anchor>
    <event_mention_argument REFID="ZBN20001228.0400.0017-E1-27" ROLE="Org">
      <extent>
        <charseq START="537" END="538">双方</charseq>
      </extent>
    </event_mention_argument>
  </event_mention>
</event>
</document>
</source_file>
